208 related articles for article (PubMed ID: 24614195)
1. Tapasin modification on the intracellular epitope HBcAg18-27 enhances HBV-specific CTL immune response and inhibits hepatitis B virus replication in vivo.
Chen X; Tang Y; Zhang Y; Zhuo M; Tang Z; Yu Y; Zang G
Lab Invest; 2014 May; 94(5):478-90. PubMed ID: 24614195
[TBL] [Abstract][Full Text] [Related]
2. [The fusion protein of cytoplasmic transduction peptide (CTP)-HBcAg18-27-Tapasin enhances specific immune response to hepatitis B virus and inhibits viral replication in transgenic mice].
Tang Y; Chen X; Zhou L; Zhuo M; Zang G; Tang Z; Yu Y
Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):24-9. PubMed ID: 24721239
[TBL] [Abstract][Full Text] [Related]
3. The modification of Tapasin enhances cytotoxic T lymphocyte activity of intracellularly delivered CTL epitopes via cytoplasmic transduction peptide.
Chen X; Liu H; Tang Z; Yu Y; Zang G
Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):203-12. PubMed ID: 23299079
[TBL] [Abstract][Full Text] [Related]
4. Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo.
Wu S; Chen X; Tang Y; Zhang Y; Li D; Chen J; Wang J; Tang Z; Zang G; Yu Y
Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):181-190. PubMed ID: 29340620
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances HBV-specific humoral and CTL immune responses in vivo.
Song L; Zhuo M; Tang Y; Chen X; Tang Z; Zang G
Int Immunopharmacol; 2014 Nov; 23(1):1-7. PubMed ID: 25135878
[TBL] [Abstract][Full Text] [Related]
6. The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice.
Chen X; Lai J; Pan Q; Tang Z; Yu Y; Zang G
Vaccine; 2010 May; 28(23):3913-9. PubMed ID: 20394723
[TBL] [Abstract][Full Text] [Related]
7. [Secretion of Th1-type cytokines and production of HBV-specific cytotoxic T lymphocytes in C57BL/6 mice induced by cytoplasmic transduction peptide-HBcAg18-27-Tapasin].
Tang Y; Chen X; Tang Z; Zang G; Yu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):229-32. PubMed ID: 23643075
[TBL] [Abstract][Full Text] [Related]
8. The Fusion Protein of CTP-HBcAg18-27-Tapasin Mediates the Apoptosis of CD8(+)T Cells and CD8(+) T Cell Response in HLA-A2 Transgenic Mice.
Tang YY; Tang ZH; Zhang Y; Zhuo M; Zang GQ; Chen XH; Yu YS
Hepat Mon; 2014 Feb; 14(2):e16161. PubMed ID: 24693311
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Tang Z; Zang G
Cell Physiol Biochem; 2017; 41(2):423-438. PubMed ID: 28214886
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice.
Zhuo M; Song L; Tang Y; Dai S; Chen X; Yu Y; Zang G; Tang Z
Mol Med Rep; 2015 Sep; 12(3):3591-3598. PubMed ID: 26004262
[TBL] [Abstract][Full Text] [Related]
11. Fusion protein of tapasin and hepatitis B core antigen 18‑27 enhances T helper cell type 1/2 cytokine ratio and antiviral immunity by inhibiting suppressors of cytokine signaling family members 1/3 in hepatitis B virus transgenic mice.
Tang Y; Chen X; Zhang Y; Tang Z; Zhuo M; Li D; Wang P; Zang G; Yu Y
Mol Med Rep; 2014 Apr; 9(4):1171-8. PubMed ID: 24535102
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
[TBL] [Abstract][Full Text] [Related]
13. HBcAg18-27 epitope fused to HIV-Tat 49-57 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic mice.
Wang S; Han Q; Zhang N; Chen J; Liu Z; Zhang G; Li Z
Immunol Lett; 2010 Jan; 127(2):143-9. PubMed ID: 19883689
[TBL] [Abstract][Full Text] [Related]
14. [Dynamic changes and clinical significance of HBcAg18-27 specific cytotoxic T lymphocytes in acute hepatitis B patients].
Li J; Han YP; Liu B; Liu Y; Chen N; Dong L; Yan YD; Jiang LF; Huang ZH
Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):38-43. PubMed ID: 21272457
[TBL] [Abstract][Full Text] [Related]
15. [HBcAg-specific CTL response induced by PTD-HBcAg fusion protein to inhibit HBV replication in vitro].
Chen XH; Pan QC; Yu YS; Tang ZH; Zang GQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):289-92. PubMed ID: 19351491
[TBL] [Abstract][Full Text] [Related]
16. An Engineered DC-Targeting Lentivector Induces Robust T Cell Responses and Inhibits HBV Replication in HBV Transgenic Mice via Upregulating T Cell Autophagy.
Ma S; Chen X; Tan Q; Dai S; Li D; Wu S; Yu Y; Zang G; Tang Z
Cell Physiol Biochem; 2018; 48(3):1041-1059. PubMed ID: 30041239
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8+ T-cell responses in HLA-A2.1/Kb transgenic mice.
Zhang Y; Li S; Shan M; Pan X; Zhuang K; He L; Gould K; Tien P
Immunology; 2007 May; 121(1):105-12. PubMed ID: 17244158
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
Xu W; Chu Y; Zhang R; Xu H; Wang Y; Xiong S
Virology; 2005 Apr; 334(2):255-63. PubMed ID: 15780875
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-modified hepatitis B virus core antigen effectively facilitates antigen presentation and enhances cytotoxic T lymphocyte activity via the cytoplasmic transduction peptide in vitro.
Song L; Zhuo M; Tang Y; Chen X; Yu Y; Tang Z; Zang G
Mol Med Rep; 2015 Jul; 12(1):289-96. PubMed ID: 25684256
[TBL] [Abstract][Full Text] [Related]
20. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice.
Sette AD; Oseroff C; Sidney J; Alexander J; Chesnut RW; Kakimi K; Guidotti LG; Chisari FV
J Immunol; 2001 Jan; 166(2):1389-97. PubMed ID: 11145724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
